BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1363195)

  • 1. Pharmacological treatment of allergies.
    De Vos C
    Allerg Immunol (Paris); 1992 Dec; 24(10):382-4. PubMed ID: 1363195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiallergic action of betotastine besilate (TAU-284) in animal models: A comparison with ketotifen.
    Ueno M; Inagaki N; Nagai H; Koda A
    Pharmacology; 1998 Oct; 57(4):206-14. PubMed ID: 9730778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiallergic properties of antihistamines.
    Negro-Alvarez JM; Funes E; García Cánovas A; Hernández J; García-Sellés FJ; Pagán JA; López-Sánchez JD
    Allergol Immunopathol (Madr); 1996; 24(4):177-83. PubMed ID: 8939275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cetirizine: more than an antihistamine?
    Bernheim J; Arendt C; de Vos C
    Agents Actions Suppl; 1991; 34():269-93. PubMed ID: 1686525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H;
    Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiallergic effects of H1-receptor antagonists.
    Baroody FM; Naclerio RM
    Allergy; 2000; 55 Suppl 64():17-27. PubMed ID: 11291777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of antihistamines on the immediate allergic response: a comparative review.
    Naclerio RM
    Otolaryngol Head Neck Surg; 1993 Jun; 108(6):723-30. PubMed ID: 8100058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The investigation of asthmatic children by multiple factor analysis. III. The changes in allergic factors selected by multiple factor analysis in 3 anti-allergic during treated groups over one year].
    Koya N; Moroi T; Hara M; Suzuki S; Tateno A; Nagata K
    Arerugi; 1989 Dec; 38(12):1334-46. PubMed ID: 2483880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert anti-allergic activity.
    Ciprandi G; Buscaglia S; Catrullo A; Pesce G; Fiorino N; Montagna P; Bagnasco M; Canonica GW
    Clin Exp Allergy; 1997 Feb; 27(2):182-91. PubMed ID: 9061218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of azelastine on microviscosity of bronchial lavage fluid obtained from actively sensitized and challenged guinea pigs.
    Achterrath-Tuckermann U; Motta C; Szelenyi I
    Agents Actions; 1989 Jan; 26(1-2):70-2. PubMed ID: 2565668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cetirizine].
    Groschner K; Pöch G
    Dtsch Med Wochenschr; 1998 Dec; 123(50):1523-4. PubMed ID: 9879282
    [No Abstract]   [Full Text] [Related]  

  • 13. The inhibitory effect of TMK688, a novel anti-allergic drug having both 5-lipoxygenase inhibitory activity and anti-histamine activity, against bronchoconstriction, leukotriene production and inflammatory cell infiltration in sensitized guinea pigs.
    Tohda Y; Nakajima S; Shizawa T; Maeda K; Ohmori S; Satoh H; Ishii T; Kamitani T
    Clin Exp Allergy; 1997 Jan; 27(1):110-8. PubMed ID: 9117875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression.
    Ciprandi G; Pronzato C; Ricca V; Passalacqua G; Danzig M; Canonica GW
    Clin Exp Allergy; 1997 Oct; 27(10):1175-83. PubMed ID: 9383258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Picumast dihydrochloride (Auteral), a new anti-allergic inhibitor of mediator release and action.
    Wilhelms OH; Roesch A; Schaumann W
    Agents Actions Suppl; 1991; 34():335-49. PubMed ID: 1686528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical azelastine has a 12-hour duration of action as assessed by histamine challenge-induced exudation of alpha 2-macroglobulin into human nasal airways.
    Greiff L; Andersson M; Svensson C; Persson CG
    Clin Exp Allergy; 1997 Apr; 27(4):438-44. PubMed ID: 9146938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibitor of chemical mediator release].
    Fujimura M
    Nihon Rinsho; 1996 Nov; 54(11):3029-33. PubMed ID: 8950949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihistamines and allergic asthma.
    De Vos C
    Allerg Immunol (Paris); 1991 Nov; 23(9):396-401. PubMed ID: 1685322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-allergic effect of azelastine hydrochloride on immediate type hypersensitivity reactions in vivo and in vitro.
    Katayama S; Akimoto N; Shionoya H; Morimoto T; Katoh Y
    Arzneimittelforschung; 1981; 31(8):1196-203. PubMed ID: 6170298
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of anti-allergic activities of the histamine H1 receptor antagonists epinastine, ketotifen and oxatomide in human leukocytes.
    Mita H; Shida T
    Arzneimittelforschung; 1995 Jan; 45(1):36-40. PubMed ID: 7893266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.